We present a case of drug-induced methemoglobinemia in a patient on a prophylaxis dose of dapsone while undergoing therapy for multiple myeloma despite having normal glucose-6-phosphate dehydrogenase (G6PD) levels, of which only a few cases have been reported so far. This evidence concerns the gene G6PD and plasma cell myeloma.